Skip to main content

Dendritic Cells Prevent CD95 Mediated T Lymphocyte Death through Costimulatory Signals

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 451))

Abstract

T cell apoptosis is a mechanism regulating T cell homeostasis. Prolonged stimulation renders T cells susceptible to activation induced cell death (AICD), a process mediated through CD95 (Apo-1/Fas). While under some circumstances AICD can be prevented, little is known about molecules involved. Here, we wanted to assess whether dendritic cells (DC) have the capacity to prevent CD95-dependent AICD. T cells activated with PHA/PMA or anti-CD3 monoclonal antibody (mAb) were cocultured with increasing amounts of DC. While spontaneous T cell apoptosis amounted to 25%, the presence of an agonistic anti-CD95 antibody increased cell death to 64%. Addition of scalar amounts of DC prevented T cell apoptosis in a dose dependent fashion, where coculture of 105 DC/ml with 106 T cells/ml reduced apoptosis almost to baseline level (33%). Further addition of an anti-CD58 antibody partially abolished this protective effect. This was even more pronounced if anti-CD80 and anti-CD86 antibodies were added. Our findings suggest that dendritic cells are able to rescue T cells from AICD, with CD58 ligation playing a key role.

The first two authors contributed equally to this work.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bruderlein, S., Henne, C, Schmidt, A., Debatin, K.M., Krammer, RH., Moller, P., 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415–29

    PubMed  CAS  Google Scholar 

  2. Daniel, P.T., Oettinger, U., Mapara, M.Y., Bommert, K., Bargou, R., Dörken, B., 1997. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/Apo-1) li-gand expression and function. Eur J Immunol 27, in press

    Google Scholar 

  3. Nagata, S., Golstein, P., 1995. The Fas death factor. Science 267, 1449–56

    Article  PubMed  CAS  Google Scholar 

  4. Dhein, J., Walczak, H., Baumler, C., Debatin, K.M., Krammer, P.H., 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438–41

    Article  PubMed  CAS  Google Scholar 

  5. Klas, C., Debatin, K. M., Jonker, R. R., Krammer, P. H., 1993. Activation interferes with the APO-1 pathway in mature human T cells, Int Immunol 5, 625–30

    Article  PubMed  CAS  Google Scholar 

  6. Tuosto, L., Piazza, C., Moretti, S., Modesti, A., Greenlaw, R., Lechler, R., Lombardi, G., Piccolella, E., 1995. Ligation of either CD2 or CD28 rescues CD4+ T cells from HIV-gp120-induced apoptosis. Eur J Immunol 25, 2917–22

    Article  PubMed  CAS  Google Scholar 

  7. Dhein, J., Daniel, P.T., Trauth, B.C., Oehm, A., Moller, P., Krammer, P.H., 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149, 3166–73

    PubMed  CAS  Google Scholar 

  8. Sanchez-Madrid, F., Krensky, A. M., Ware, C. F., Robbins, E., Strominger, J. L., Burakoff, S. J., Springer, T. A., 1982. Three distinct antigens associated with human T-lymphocyte mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci USA 79, 7489–93

    Article  PubMed  CAS  Google Scholar 

  9. Ohno, H., Ushiyama, C., Taniguchi, M., Germain, R. N., Saito, T., 1991. CD2 can mediate TCR/CD3-inde-pendent T cell activation. J Immunol 146, 3742–6

    PubMed  CAS  Google Scholar 

  10. Meuer, S.C., Hussey, R.E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K.A., Hodgdon, J.C., Protentis, J.P., Schlossman, S.F., Reinherz, E.L., 1984. An alternative pathway of T-cell activation: a functional role for the 50 kd Tl 1 sheep erythrocyte receptor protein. Cell 36, 897–906

    Article  PubMed  CAS  Google Scholar 

  11. Wesselborg, S., Prüfer, U., Wild, B., Schraven, B., Meuer, S. C., Kabelitz, D., 1993. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 23, 2707–10

    Article  PubMed  CAS  Google Scholar 

  12. Lenschow, D.J., Walunas, T.L., Bluestone, J.A., 1996. CD28/B7 system of T cell costimulation. Ann. Rev Immunol. 14, 233–58

    Article  CAS  Google Scholar 

  13. Boise, L.H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., Thompson, C. B., 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3, 87–98

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter T. Daniel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Daniel, P.T., Scholz, C., Westermann, J., Dörken, B., Pezzutto, A. (1998). Dendritic Cells Prevent CD95 Mediated T Lymphocyte Death through Costimulatory Signals. In: Walden, P., Trefzer, U., Sterry, W., Farzaneh, F., Zambon, P. (eds) Gene Therapy of Cancer. Advances in Experimental Medicine and Biology, vol 451. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5357-1_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5357-1_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7444-2

  • Online ISBN: 978-1-4615-5357-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics